Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymic dysfunction in histiocytosis-X.

R Consolini, P Cini, B Cei

    The American Journal of Pediatric Hematology/Oncology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rasmussen's encephalitis: From immune pathogenesis towards targeted-therapy.

    Seizure·2020
    Same author

    Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.

    Clinical and experimental immunology·2020
    Same author

    Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome.

    Epilepsy & behavior reports·2020
    Same author

    Generalized epilepsy and mild intellectual disability associated with 13q34 deletion: A potential role for SOX1 and ARHGEF7.

    Seizure·2018
    Same author

    Unusual onset of a case of chronic recurrent multifocal osteomyelitis.

    Pediatric rheumatology online journal·2015
    Same author

    Antiproliferative effects of 5-fluorouracil and oxaliplatin in colon cancer cell lines: comparison of three different cytotoxicity assays.

    Journal of biological regulators and homeostatic agents·2013
    Same journal

    Transient abnormal myelopoiesis in Down's syndrome neonates.

    The American journal of pediatric hematology/oncology·1994
    Same journal

    Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.

    The American journal of pediatric hematology/oncology·1994
    Same journal

    Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma.

    The American journal of pediatric hematology/oncology·1994
    Same journal

    Sphenoid sinus involvement in neuroblastoma.

    The American journal of pediatric hematology/oncology·1994
    Same journal

    Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.

    The American journal of pediatric hematology/oncology·1994
    Same journal

    Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome.

    The American journal of pediatric hematology/oncology·1994
    See all related articles

    Histiocytosis-X patients show suppressor T cell deficiencies, potentially linked to thymus dysfunction. Thymic hormone therapy, like thymulin, may help by stimulating these crucial immune cells.

    Area of Science:

    • Immunology
    • Endocrinology
    • Pediatric Pathology

    Background:

    • Histiocytosis-X is associated with suppressor T cell deficiencies.
    • Evidence suggests a potential role for thymus dysfunction in the disease pathogenesis.
    • Low serum thymic factor (FTS) levels are observed in affected patients.

    Purpose of the Study:

    • To investigate the immunological defect in histiocytosis-X.
    • To explore the role of thymic factor (FTS) and its inhibition in the disease.
    • To evaluate the potential of thymic hormone therapy.

    Main Methods:

    • In vitro correction of T cell deficiency using calf thymic extract and thymostimulin.
    • Measurement of serum thymic factor (FTS) levels.
    • Analysis of plasma factors inhibiting FTS biological activity.

    Related Experiment Videos

    Main Results:

    • Suppressor T cell deficiency in some histiocytosis-X patients was corrected by thymic extracts.
    • Low serum thymic factor (FTS) levels were detected in patients.
    • Patient plasma contained inhibitors of FTS biological activity in vitro.

    Conclusions:

    • Histiocytosis-X may stem from a primary immunodeficiency syndrome involving thymic dysfunction.
    • Thymic hormone therapy, particularly with thymulin, shows promise for treatment by enhancing suppressor T cells.